-
1
-
-
0028786997
-
Oral anticoagulants. Mechanism of action, clinical effectiveness and optimal therapeutic range
-
1. Hirsh J, Dalen JE, Deykin D, Pollen L, Bussey H. Oral anticoagulants. Mechanism of action, clinical effectiveness and optimal therapeutic range. Chest 1995; 108: 231S-3S.
-
(1995)
Chest
, vol.108
-
-
Hirsh, J.1
Dalen, J.E.2
Deykin, D.3
Pollen, L.4
Bussey, H.5
-
2
-
-
0029869807
-
Prevalence of atrial fibrillation with prior and new thromboembolic stroke in older patients
-
2. Aronow WS, Ahn C, Gutstein H. Prevalence of atrial fibrillation with prior and new thromboembolic stroke in older patients. J Am Geriatr Soc 1996; 44: 521-3.
-
(1996)
J Am Geriatr Soc
, vol.44
, pp. 521-523
-
-
Aronow, W.S.1
Ahn, C.2
Gutstein, H.3
-
4
-
-
0027097571
-
Aging and the anticoagulant response to warfarin
-
4. Gurwitz JH, Avorn J, Ross-Degnan D, Choodnovskiy I, Ansell J. Aging and the anticoagulant response to warfarin. Ann Intern Med 1992; 116: 901-4.
-
(1992)
Ann Intern Med
, vol.116
, pp. 901-904
-
-
Gurwitz, J.H.1
Avorn, J.2
Ross-Degnan, D.3
Choodnovskiy, I.4
Ansell, J.5
-
5
-
-
0017684375
-
Determinants of anticoagulant control in patients receiving warfarin
-
5. O'Malley K, Stevenson IH, Ward CA, Wood AJ, Crooks J. Determinants of anticoagulant control in patients receiving warfarin. Br J Clin Pharmacol 1977; 4: 309-14.
-
(1977)
Br J Clin Pharmacol
, vol.4
, pp. 309-314
-
-
O'Malley, K.1
Stevenson, I.H.2
Ward, C.A.3
Wood, A.J.4
Crooks, J.5
-
6
-
-
0030317303
-
The risk for and severity of bleeding complications in elderly patients treated with warfarin
-
6. Fihn SD, Callahan CM, Maertin DC, McDonnell MB, Hennikoff JG, White RH. The risk for and severity of bleeding complications in elderly patients treated with warfarin. Ann Intern Med 1996; 124: 970-9.
-
(1996)
Ann Intern Med
, vol.124
, pp. 970-979
-
-
Fihn, S.D.1
Callahan, C.M.2
Maertin, D.C.3
McDonnell, M.B.4
Hennikoff, J.G.5
White, R.H.6
-
7
-
-
0021249057
-
Flexible induction dose regimen for warfarin and prediction of maintenance dose
-
7. Fennerty A, Dolben J, Thomas P et al. Flexible induction dose regimen for warfarin and prediction of maintenance dose. Br Med J 1984; 288: 1268-70.
-
(1984)
Br Med J
, vol.288
, pp. 1268-1270
-
-
Fennerty, A.1
Dolben, J.2
Thomas, P.3
-
9
-
-
0023726356
-
The incidence, magnitude, and time course of the amiodarone-warfarin interaction
-
9. Kerin NZ, Blevins RD, Goldman L, Faitel K, Rubenfire M. The incidence, magnitude, and time course of the amiodarone-warfarin interaction. Arch Intern Med 1988; 148: 1779-81.
-
(1988)
Arch Intern Med
, vol.148
, pp. 1779-1781
-
-
Kerin, N.Z.1
Blevins, R.D.2
Goldman, L.3
Faitel, K.4
Rubenfire, M.5
-
10
-
-
0023625745
-
Atrial fibrillation: A major contributor to stroke in the elderly. The framingham study
-
10. Wolf PA, Abbott RD, Kannel WD. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham study. Arch Intern Med 1987; 147: 1561-4.
-
(1987)
Arch Intern Med
, vol.147
, pp. 1561-1564
-
-
Wolf, P.A.1
Abbott, R.D.2
Kannel, W.D.3
-
11
-
-
0032521255
-
Warfarin anticoagulation and survival: A cohort analysis from the studies of left ventricular dysfunction
-
11. Al-Khadra AS, Salem DN, Rand WM, Udelson JE, Smith JJ, Konstam MA. Warfarin anticoagulation and survival: a cohort analysis from the studies of left ventricular dysfunction. JACC 1998; 31: 749-53.
-
(1998)
JACC
, vol.31
, pp. 749-753
-
-
Al-Khadra, A.S.1
Salem, D.N.2
Rand, W.M.3
Udelson, J.E.4
Smith, J.J.5
Konstam, M.A.6
-
12
-
-
0026176358
-
Standardized initial warfarin treatment: Evaluation of initial response and maintenance dose prediction by randomised trial, and risk factors for an excessive warfarin response
-
12. Doecke CJ, Cosh DG, Gallus AS. Standardized initial warfarin treatment: evaluation of initial response and maintenance dose prediction by randomised trial, and risk factors for an excessive warfarin response. Aust NZ J Med 1991; 21: 319-24.
-
(1991)
Aust NZ J Med
, vol.21
, pp. 319-324
-
-
Doecke, C.J.1
Cosh, D.G.2
Gallus, A.S.3
-
13
-
-
0029123928
-
The influence of age, liver size and enantiomer concentrations on warfarin requirements
-
13. Wynne H, Cope L, Kelly P, Whittingham T, Edwards C, Kamali F. The influence of age, liver size and enantiomer concentrations on warfarin requirements. Br J Clin Pharmacol 1995; 40: 203-7.
-
(1995)
Br J Clin Pharmacol
, vol.40
, pp. 203-207
-
-
Wynne, H.1
Cope, L.2
Kelly, P.3
Whittingham, T.4
Edwards, C.5
Kamali, F.6
-
14
-
-
0014730072
-
Vitamin K deficiency in the elderly
-
14. Hazell K, Baloch KH. Vitamin K deficiency in the elderly. Geront Clin 1970; 12: 10-7.
-
(1970)
Geront Clin
, vol.12
, pp. 10-17
-
-
Hazell, K.1
Baloch, K.H.2
-
15
-
-
0029564238
-
Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirements in patients undergoing anticoagulation therapy
-
15. Furuya H, Fernandez-Salguero P, Gregory W et al. Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirements in patients undergoing anticoagulation therapy. Pharmacogenetics 1995; 5: 389-92.
-
(1995)
Pharmacogenetics
, vol.5
, pp. 389-392
-
-
Furuya, H.1
Fernandez-Salguero, P.2
Gregory, W.3
-
19
-
-
0009539352
-
Warfarin sensitivity in the elderly
-
Crooks J, Stevenson IH (Eds). Baltimore: University Park Press
-
19. Shepherd AMM, Wilson M, Stevenson IH. Warfarin sensitivity in the elderly. In: Crooks J, Stevenson IH (Eds). Drugs and the elderly. Baltimore: University Park Press, 1979.
-
(1979)
Drugs and the Elderly
-
-
Shepherd, A.M.M.1
Wilson, M.2
Stevenson, I.H.3
|